Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Tussilago farfara
L'une des Bermuda les plus anciennes herbes respiratoires européennes ; la tussilagine et la mucilage apaisent les toux ; le contenu d'alcaloïdes pyrrolidiques limite la durée d'utilisation interne.
Coltsfoot leaf (Tussilago farfara) is a traditional European respiratory herb valued for its antitussive and expectorant properties, primarily attributed to tussilagone and mucilage. Its clinical use is limited by the presence of hepatotoxic pyrrolizidine alkaloids, restricting internal administration to short-term (≤2 weeks). Evidence supports its efficacy for acute cough and bronchitis, but safety concerns necessitate caution.
Tussilagone, a sesquiterpene lactone, stimulates respiratory ciliary activity and enhances mucociliary clearance, while also exhibiting anti-inflammatory effects via inhibition of NF-κB and COX-2 pathways. Mucilage forms a protective film over pharyngeal mucosa, reducing irritation and cough reflex. Pyrrolizidine alkaloids undergo hepatic bioactivation to toxic metabolites, causing veno-occlusive disease and hepatotoxicity, which limits duration of use.
L'une des Bermuda les plus anciennes herbes respiratoires européennes ; la tussilagine et la mucilage apaisent les toux ; le contenu d'alcaloïdes pyrrolidiques limite la durée d'utilisation interne.
Coltsfoot leaf (Tussilago farfara) is a traditional European respiratory herb valued for its antitussive and expectorant properties, primarily attributed to tussilagone and mucilage. Its clinical use is limited by the presence of hepatotoxic pyrrolizidine alkaloids, restricting internal administration to short-term (≤2 weeks). Evidence supports its efficacy for acute cough and bronchitis, but safety concerns necessitate caution.
Tussilagone, a sesquiterpene lactone, stimulates respiratory ciliary activity and enhances mucociliary clearance, while also exhibiting anti-inflammatory effects via inhibition of NF-κB and COX-2 pathways. Mucilage forms a protective film over pharyngeal mucosa, reducing irritation and cough reflex. Pyrrolizidine alkaloids undergo hepatic bioactivation to toxic metabolites, causing veno-occlusive disease and hepatotoxicity, which limits duration of use.